Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7777]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Genes, chromosomes and the treatment of bladder cancer
Dr Jonathan Rosenburg - Memorial Sloan Kettering Cancer Center, New York, USA
Genes, chromosomes and the treatment of bladder cancer ( Dr Jonathan Rosenburg - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Oct 2012
Surgical challenges to retroperitoneal sarcomas
Dr Angelo Dei Tos – Department of Oncology, General Hospital of Treviso, Italy
Surgical challenges to retroperitoneal sarcomas ( Dr Angelo Dei Tos – Department of Oncology, General Hospital of Treviso, Italy )
9 Oct 2012
Treatment approaches for desmoid tumours
Dr Sylvie Bonvalot – Institut Gustave Roussy, Paris, France
Treatment approaches for desmoid tumours ( Dr Sylvie Bonvalot – Institut Gustave Roussy, Paris, France )
9 Oct 2012
Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype
Dr Fatima Cardoso – Champalimaud Cancer Center, Lisbon, Portugal
Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype ( Dr Fatima Cardoso – Champalimaud Cancer Center, Lisbon, Portugal )
9 Oct 2012
Clinical trials and drug developments in pancreatic cancer
Dr Roberto Labianca – Ospedali Riuniti Bergamo, Italy
Clinical trials and drug developments in pancreatic cancer ( Dr Roberto Labianca – Ospedali Riuniti Bergamo, Italy )
9 Oct 2012
The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast...
Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy
The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast conservation surgery ( Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy )
9 Oct 2012
Histology and non-histology driven therapy for soft tissue sarcomas and the...
Dr Paolo Casali – Instituto Nazionale Tumori, Milan, Italy
Histology and non-histology driven therapy for soft tissue sarcomas and the Rare Cancers Europe initiative ( Dr Paolo Casali – Instituto Nazionale Tumori, Milan, Italy )
9 Oct 2012
MET inhibitors for non-small cell lung cancer
Prof Georgio Scagliotti – University of Torino, Italy
MET inhibitors for non-small cell lung cancer ( Prof Georgio Scagliotti – University of Torino, Italy )
9 Oct 2012
Multidisciplinary benefits to radiotherapy
Prof Vincenzo Valentini – President of ESTRO
Multidisciplinary benefits to radiotherapy ( Prof Vincenzo Valentini – President of ESTRO )
9 Oct 2012
Putting the theory of personalised medicine into practice
Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert...
Putting the theory of personalised medicine into practice ( Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard )
8 Oct 2012
Treatment of ALK+ lung cancer with crizotinib, Profile 1007
Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
Treatment of ALK+ lung cancer with crizotinib, Profile 1007 ( Dr Alice Shaw – Massachusetts General Hospital, Boston, USA )
8 Oct 2012
Phase III MISSION trial: Sorafenib does not extend overall survival as third or...
Dr Tony Mok – The Chinese University of Hong Kong
Phase III MISSION trial: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer ( Dr Tony Mok – The Chinese University of Hong Kong )
8 Oct 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation